Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).
Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.
Québec, Québec
Canada G1E 7G9
Latest news
- [Le Chuchoteur] Recherche clinique en vaccinologie : optimiser l’utilisation des vaccins 2023-03-27
- [ULaval Nouvelles] Michel G. Bergeron et Gaston De Serres promus au rang d’émérite 2022-10-28
- [ULaval Nouvelles] COVID-19: une infection pré-Omicron assure une bonne protection contre les hospitalisations causées par Omicron 2022-10-19
- Audet, ChristianeEmployeechristiane.audet@crchudequebec.ulaval.ca
- Audet, ChristianeEmployeechristiane.audet@crchudequebec.ulaval.ca
- Audet, DianeEmployee2400, avenue d'Estimauville+1 418-666-7000, extension 10218+1 418-666-2776diane.audet2.ciussscn@ssss.gouv.qc.cadiane.audet@crchudequebec.ulaval.ca
3e étage
Québec, Québec
Canada G1E 7G9 - Babou Kammoe, Romuald BriceEmployeeCHUL+1 418-525-4444, extension 42296Romuald.Babou@crchudequebec.ulaval.ca
2705 Boulevard Laurier
T1-49
Québec, QC
Canada G1v 4G2 - Bellavance, CharlesEmployeecharles.bellavance@crchudequebec.ulaval.ca
- Berrehail, ZohraEmployeeCHUL+1 418-525-4444, extension 48288zohra.berrehail@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Boucher, CatherineEmployeeCHUL+1 418-525-4444, extension 42296catherine.boucher@crchudequebec.ulaval.ca
2705, boulevard Laurier
T3-67
Québec, QC
Canada G1V 4G2 - Coulombe, CatherineEmployee2400 Avenue D'Estimauville+1 418-666-7000, extension 10216catherine.coulombe2.ciussscn@ssss.gouv.qc.cacatherine.coulombe@crchudequebec.ulaval.ca
Pavillon Arthur-Vallée
U3302
Québec, QC
Canada G1E 6W2 - Deloye, SimonEmployeesimon.deloye@crchudequebec.ulaval.ca
- Drescher, OliviaEmployee2875, boulevard Laurier, Édifice Delta II, 6e étage, bureau 600+1 418-525-4444, extension 46523+1 418-654-2726olivia.drescher@crchudequebec.ulaval.ca
Québec, Québec
Canada G1V 2M2 - Febriani, YossiEmployeeyossi.febriani@crchudequebec.ulaval.ca
- Gosselin, GhislaineEmployeeCHULghislaine.gosselin@crchudequebec.ulaval.ca
2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2 - Hegg-Deloye, SandrineEmployee2400, ave. d'Estimauville
Québec, QC
Canada G1E 7G9CHUL+1 418-525-4444, extension 43787+1 418-666-7000, extension 10220Sandrine.hegg-deloye.1@ulaval.caSandrine.Hegg-Deloye@crchudequebec.ulaval.ca
2705, boulevard Laurier
T1-49
Québec, QC
Canada G1V 4G2 - Issa Kana, Kode Djogo NyazyMaster studentkode-djogo-nyazy.issa-kana@crchudequebec.ulaval.ca
- Landry, MyriamEmployeemyriam.landry@crchudequebec.ulaval.ca
- Laverdière, DanyEmployee2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9CHUL+1 418-525-4444, extension 42296+1 418-666-7000, extension 10226+1 418-666-2776dany.laverdiere.ciussscn@ssss.gouv.qc.cadany.laverdiere@crchudequebec.ulaval.ca
2705, boulevard Laurier
TR-83
Québec, QC
Canada G1V 4G2 - Mansour, ThowibaEmployeethowiba.mansour.1@ulaval.cathowiba.mansour@crchudequebec.ulaval.ca
- Razafimandimby Andriamandamina, HarimahefaEmployeeharimahefa.razafimandimby@crchudequebec.ulaval.ca
- Saim-Mamoun, AmelEmployeeCHUL+1 418-525-4444, extension 48907amel.saim-mamoun@crchudequebec.ulaval.ca
2705 Boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Shakibaian, SarahEmployeesarah.shakibaian@crchudequebec.ulaval.ca
Timing and Predictors of Loss of Infectivity among Healthcare Workers with Mild Primary and Recurrent COVID-19: a Prospective Observational Cohort Study
Journal ArticleClin Infect Dis, 2023.
Factors associated with intention for revaccination among patients with adverse events following immunization
Journal ArticleVaccine, 2023.
Infection-induced seroconversion and seroprevalence of SARS-CoV-2 among a cohort of children and youth in Montreal, Canada
Journal ArticleInfluenza Other Respir Viruses, 17 (8), 2023.
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada
Journal ArticleLancet Healthy Longev, 4 (8), 2023.
Pre-Omicron seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and teenagers in Montréal, Canada
Journal ArticleInt J Infect Dis, 131 , 2023.
Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination
Journal ArticleVaccines (Basel), 11 (2), 2023.
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
Journal ArticleEuro Surveill, 28 (5), 2023.
BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12-17 Years, by Dosing Interval and Duration
Journal ArticleJ Infect Dis, 227 (9), 2023.
Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
Journal ArticleCell Rep, 42 (1), 2023.
Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection From the Canadian National Vaccine Safety Network
Journal ArticleClin Infect Dis, 76 (6), 2023.
Active projects
- (SI03 QC03) Special Immunization Clinic Network (SIC) to investigate vaccine safety issues: Optimizing the clinical management of patients with contraindication to vaccination ..., from 2019-04-01 to 2024-03-31
- CV07 QC03 Canadian National Vaccine Safety (CANVAS) network: Surveillance of Adverse Events Following Immunization among children and adults Immunized with the COVID-19 Vaccine, from 2021-04-01 to 2023-09-30
- Enquête sérologique chez les travailleurs de la santé qui rapportent n’avoir jamais fait la COVID-19 depuis le début de la pandémie, from 2023-04-20 to 2023-12-31
- Fréquence et séquelles fonctionnelles du syndrome post-COVID-19 chez les travailleurs de la santé , from 2023-03-02 to 2025-07-31
- HPV vaccination effectiveness in a Canadian setting, 12 years after implementation: are we on the road to eliminate cervical, from 2020-10-01 to 2024-09-30
- SI05 QC03, Optimizing the clinical management of patients with adverse events following COVID-19 vaccination and potential contraindications to vaccination in the Special Immunization Clinic Network, from 2021-11-01 to 2024-03-31
- SI06 QC03, Optimizing the clinical management of patients with adverse events following COVID-19 vaccination and potential contraindications to vaccination in the Special Immunization Clinic Network, from 2021-04-01 to 2023-10-31
- The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context, from 2022-10-01 to 2025-09-30
Recently finished projects
- (CV04 QC03) CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, from 2017-06-01 to 2022-03-31
- Canadian Immunization Research Network, from 2014-06-01 to 2021-12-31
- Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) COVID-19 Vaccine Post-Market Studies, from 2020-12-01 to 2023-06-30
- Efficacité des vaccins contre la CVOID-19, from 2021-04-20 to 2022-06-30
- Identification de stratégies pour outiller les gestionnaires des milieux de soins pour l’application optimale des mesures de prévention et contrôle des infections chez les travailleurs de la santé durant la pandémie de COVID-19, from 2021-01-01 to 2022-02-08
- Prize 202203PJT - The test-negative design for the estimation of COVID-19 vaccine effectiveness: design evaluation and development of statistical methods in the evolving context, from 2022-10-01 to 2023-03-31
- Surveillance des manifestations cliniques survenant après la vaccination contre la COVID-19 au Québec, from 2020-12-01 to 2021-12-31